CRISPR/Cas9 technology was used to introduce an alanine for threonine substitution at codon 991 (T991A) in exon 22. The T991A mutation has been identified in a patient with severe peripheral neuropathy, abolishes Thr991 phosphorylation, is a gain of function mutation and results in constitutive activity. This line corresponds to line #31. (J:259728)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count